Fidato Wealth
REGN icon

Fidato Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Fidato Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$227K Buy
+300
New +$227K 0.12% 28
2025
Q2 		– Sell
-352
Closed -$223K – 24
2025
Q1 		$223K Buy
352
+2
+0.6% +$1.38K 0.17% 22
2024
Q4 		$249K Buy
+350
New +$294K 0.19% 20

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.22B AUM 4.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fidato Wealth's REGN Position: Q3 2026 in Review

Fidato Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 300 shares worth $227K. The stake represents 0.12% of the portfolio and ranks #28 among its holdings. This is a return to the name: Fidato Wealth previously reported a position in REGN as recently as Q1 2025.

Fidato Wealth first reported a position in REGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $249K in Q4 2024. 467 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Fidato Wealth held 300 shares of Regeneron Pharmaceuticals worth $227K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Fidato Wealth position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.12% of Fidato Wealth's portfolio in Q3 2026, its #28 holding.
  • Fidato Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Fidato Wealth's Regeneron Pharmaceuticals position peaked at $249K in Q4 2024.
  • 467 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Fidato Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.